Oracle has released version 26 of the Java programming language and virtual machine. As the first non-LTS release since JDK ...

Four years on from the devastating Lismore floods the disaster recovery program that followed is being wound down. Hundreds of millions of dollars have been spent on a house buyback program. And while ...

Anthropic opened its virtual "Briefing: Enterprise Agents" event on Tuesday with a provocation. Kate Jensen, the company's head of Americas, told viewers that the hype around enterprise AI agents in ...

All $205 million in federal funds for the Gateway rail tunnel construction program that had been frozen by the Trump administration has now been released to the agency overseeing the project — and ...

Pilgrim Rest Baptist Church is inviting the community to attend its upcoming Black History Program on Sunday, February 22 at 3:00 p.m. The program will be held at the church, located at 4309 TX-149 in ...

MILAN — Amber Glenn bailed and Alysa Liu gasped. Liu could talk for hours about Glenn—Liu could talk for hours about anything—but at that moment, in the media mixed zone at Milano MSK Competition rink ...

– Positive, updated Phase 2 SOLSTICE data showed combination of tobevibart and elebsiran is well tolerated and achieved undetectable HDV RNA in 88% of chronic hepatitis delta participants evaluable at ...

Learn how to use advanced techniques like short-circuiting, parallel execution, virtual threads, and stream gatherers to maximize Java stream performance. My recent Java Stream API tutorial introduced ...

Agreement underscores Norgine's mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceuticals. Vir Biotechnology's chronic hepatitis delta ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty ...

– Vir Biotechnology (VIR) to receive EUR 55 million initial reimbursement payment upon closing, and up to EUR 495 million in clinical, regulatory and sales milestones, along with tiered, mid-teen to ...